Aug 2, 2024, 04:58
Learn about Roger Wilson‘s story as a sarcoma patient and the founder of Sarcoma UK
EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:
“Roger Wilson is a sarcoma patient and the founder of Sarcoma UK one of EORTC’s funding partners of the STRASS/STREXIT 2 clinical trial.
He is also the Honorary President and an active Board member of the Sarcoma Patient Advocacy Global Network (SPAGN).
Learn more about his story and involvement in the EORTC-lead STREXIT 2 Project in this insightful interview.”
Source: EORTC/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46